Herbal Medicinal Products Market Share accelerating a CAGR during the forecast period 2023-2032

 

Market Insights

Herbal medicinal products are medicinal products which have been prepared using plant or other natural sources. Herbal plants have a number of medically relevant natural ingredients which can be used in the production of dietary supplements, ointments and a variety  of other medical products. Market Research Future has performed a detailed study regarding the growth of the herbal medicinal products market share is anticipated to grow USD 21.01 billion by 2032 at a healthily CAGR of 12.2 % over the assessment period from 2023 to 2032.

Due to urbanization and the adoption of busy lifestyles, chronic diseases and other lifestyle problems are at an all-time high. Consumers are increasingly becoming health conscious and aware regarding various vital ingredients in medicine and food products. As a result, increasing consumer demand has been witnessed for green label products that are largely composed of natural ingredients. Moreover, allopathic medicine famously uses synthetic chemicals and other ingredients which can cause side effects. The growing awareness regarding these ill effects of allopathic medicine is expected to drive the growth of the herbal medicinal products market insights. Although it is recommended that consumers consult their doctor before consumption of any medically relevant products, herbal medical products are often very safe to take and do not require a prescription. In certain parts of the world, traditional herbal medicine is still embraced, driving consistent demand. Additionally, there is a low processing cost associated with herbal medicinal products which are also expected to boost market growth over the assessment period.

Notably, the market's growth is hindered by the lack of government support for the promotion of herbal medicinal products. The presence of market players who promote herbal medicinal products which are untested and have no medicinal value is also expected to challenge market growth. However, R&D activities regarding herbal ingredients will likely mitigate some challenges and prove the market with room to grow.

Key Players

Herbal Medicinal Products Market players are included in

Young Living Essential Oils LC (U.S.), ARKOPHARMA Laboratories Company Ltd. (France), Nature's Answer, Inc. (U.S.), TSUMURA & CO. (Japan), Ricola AG (Switzerland), Bio-Botanica Inc. (U.S.), and Sanofi-Aventis Healthcare Pty Ltd. (Australia) are the more prominent market participants in the global herbal medicinal products market. MRFR has identified and recorded pertinent information regarding these players competitive roles in the market.

Market Segmentation

The global herbal medicinal products market outlook has been segmented on the basis of type, function, form, and region. Types of herbal medicinal products have been segmented into homeopathic medicines, traditional Chinese medicines, aromatherapy medicines, ayurvedic medicines, and others. Ayurvedic medicines possess the largest share of the market, and the segment is followed by Chinese medicine. Ayurvedic formulations are in high demand are often easily approved for distribution by the relevant regulatory authorities. 

Function has been segmented to include  cardiovascular health, general wellness, gut & digestive health, cognitive health, and others. Gut and digestive health is the dominating segment among the mentioned segments. The increasing demand and use of herbal medicinal products for digestive problems are expected to drive the market. Herbal medicines for cardiovascular health have been witnessed to have a growing demand.

Forms of herbal medicinal products have been segmented into syrups, powder, ointments, capsules, tablets, oils, and others. Tablets lead the market and are followed by capsules as they deliver the ideal dosage of herbal medicinal ingredients . Tablets and capsules are also easy to store and carry.

Regional Analysis

MRFR has covered regions such as Asia Pacific, Europe, North America and Rest of the World. Europe leads the market with the largest share and is followed by the Asia Pacific regional market. Europe has been observed to be having the highest consumption and demand for herbal medicinal products. The rising awareness regarding herbal ingredients and the support of relevant government bodies for new product launches will likely be key in the region's growth. Meanwhile, the APAC is growing rapidly due to the high adoption of products which include herbal ingredients. Country-level markets such as India and China are the birthplaces of ayurvedic medicine and Chinese medicine respectively. As such the region has an affinity toward the adoption of herbal medicinal products over allopathic medicinal products.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Enteral Feeding Devices Market Outlook, Trends, Size, Share, Players, Scope, Regional Demand and Forecast To 2032

 

Market Overview

The global Enteral Feeding Devices Market share is predicted to meet the market value of USD 6.01 Billion by 2032 at a 5.10% CAGR for the forecast period of 2023 to 2032, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global Enteral Feeding Devices Market.

Competitive Analysis:

Leading Enteral Feeding Devices Market Players include:  

§  Medtronic plc,

§  Cook Medical,

§  B. Braun Melsungen AG,

§  Abbott Laboratories,

§  Boston Scientific Corporation,

§  Becton,

§  Dickinson and Company (BD),

§  Fresenius Kabi AG,

§  Danone Nutricia,

§  Nestlé,

§  CONMED Corporation,

§  Moog, Inc.,

§  Halyard Health, Inc., and

§  Vygon SA.

Segmentation:

The global enteral feeding devices market outlook has been segmented on the basis of product, age group, indication, end user, and region. 

·         By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

·         On the basis of age group, the market has been divided into adults and pediatrics. 

·         By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

·         Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

Major players in the global enteral feeding devices market  are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period. 

Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013                

Corporate Wellness Market Share, Size, Trends, Industry Analysis Report, By End-Use; By Application; By Type; By Region; Segment by 2030

 

Market overview

The global corporate wellness market share is estimated to exhibit growth by expanding at 8.5% during the forecast period 2022-2030 to reach a valuation of USD 114.4 billion by 2030. This growth is attributable to the higher acceptance of corporate wellness programs, which are designed to evaluate the employee’s health.

Additionally, these wellness programs are designed to estimate the probable health risks and promote healthy behavior at the workplace. Thus, these programs promote a healthy environment at workplaces and enhance productivity by lower healthcare spending substantially. Such factors are driving growth of the global corporate wellness market.

Further, the adoption of such programs results in improve morale & quality of work and decreases absenteeism; thus, several organizations are adopting corporate wellness programs. Rising prevalence of obesity, smoking, alcoholism, and other chronic diseases among white-collar workers especially in the private sector are boosting the adoption of corporate wellness. According to the data by the World Health Organization (WHO), more than 1.1 billion people were smoking tobacco in 2015. Additionally, the prevalence of obesity has tripled from the past three decades. Such data are reflecting the need for the adoption of corporate wellness programs among employers to keep their employees healthy to deliver quality work on time. This is a key factor estimated to drive growth of the global corporate wellness market in the coming years.

Competitive Analysis:

The global corporate wellness market players include ComPsych Corporation, SOL Wellness, Wellness Corporate Solutions, LLC, Wellsource, Inc., Truworth Health Technologies Pvt. Ltd., Central Corporate Wellness, Virgin Pulse, EXOS, Marino Wellness, Privia Health, ProvantHealth (Hooper Holmes, Inc.), The Vitality Group, Inc., Sodexo Group, and Bupa Wellness Pty Ltd.

Segmentation:

The global corporate wellness market outlook has been segmented into category, service type, end user, and region.

By service type, the market is segmented into stress management, health risk assessment, nutrition & weight management, fitness, smoking cessation, health screening, and others. Of these, the health risk assessment segment dominated the global corporate wellness market in 2017 owing to the increasing adoption of wellness programs for wellbeing and assessment of health risks of employees. Additionally, implementation of the appropriate intrusion strategies and promotion of adopting a healthy lifestyle are benefiting the segmental growth.

On the basis of category, the market is segmented into psychological therapists, fitness & nutrition consultants, and organizations.

Based on end users, the market is segmented into medium-scale businesses, small-scale businesses, and large-scale businesses.

Regional Analysis:

Regionally, the corporate wellness market insights is segmented into the Americas, Asia-Pacific, Europe, and Middle East & Africa. Of these, North America dominated the global corporate wellness market in 2017 and is estimated to remain dominant during the forecast period owing to the presence of corporate wellness program providers coupled with a substantial increase in the prevalence of chronic diseases in the region. Additionally, the most significant expenditure on healthcare in the region and surge in the adoption of wellness activities in Canada and the U.S.

Further, Europe is likely to hold the second-largest share in the revenue of the corporate wellness market owing to the increasing activeness of European employees and employers. Additionally, corporate wellness programs are increasingly taking a crucial part of medium or large organizations in the region, which is augmenting the growth of the market. The corporate wellness programs have become the strategic priority in European organizations; thus, the market in the region is flourishing continuously. However, the market in the Asia Pacific is estimated to expand by exhibiting a faster CAGR owing to robust industrialization and urbanization in the region. In addition to this, the increasing awareness about the health of employees due to the effects of long working hours and larger workload in countries such as India and China are estimated to benefit the market growth in the coming years as well.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Acupuncture Market Players, Industry Trends Analysis Report by Technology, By End User & By Product

 

Market overview

Market Research Future (MRFR) has launched a new release on the global acupuncture market. The report provides comprehensive coverage of the market’s growth prospects over the forecast period till 2032, based on a detailed analysis of the market’s key growth drivers and markers derived from the market’s historical growth trajectory. The global acupuncture market size is projected to reach at USD 157.73 billion by 2030 at a CAGR 17.10% during forecast period 2023-2032, according to the report.

Acupuncture is a part of traditional Chinese medicine (TCM) and consists of lightly piercing a patient’s body with small needles in order to influence and manipulate the flow of the patient’s life force, or “qi”, an essential concept in TCM. The needles are placed at strategic spots chosen due to their connection with the overall flow of qi within the patient’s body. The technique of acupuncture emerged in ancient China, but has gained significant popularity in modern-day U.S. The growth of the New Age movement has considerably helped spread the acupuncture market in Western regions, where it is now considered a pseudoscience but an established part of the wide spectrum of alternative medicine.

Acupuncture has been shown to have some effect in pain treatment; however, evidence demonstrating its efficacy in treating other medical conditions and even serious pain resulting from potentially terminal conditions is lacking. Acupuncture is now also being used in gynecological conditions related to menopause or PMS. Most of the clinical effects of acupuncture are thought to originate from the placebo effect and the overall calming effect of the setting, which may help in pain relief on its own. Nevertheless, the growing demand for alternative medicine in the U.S. has emerged as a significant driver for the global acupuncture market. On the other hand, the lack of insurance coverage for acupuncture and relatively expensive per-visit fees could hamper the market’s growth prospects in Western economies over the forecast period.

Competitive Analysis:

Global Acupuncture Market Players are Wuxi Jiajian Medical Instruments Co. Ltd., 3B Scientific GmbH, Zepter International, MKW Laser System GmbH, Qingdao Great Fortune Co. Ltd., AcuMedic Ltd., Asia-med GmbH, Cymedics GmbH & Co. KG, SEIRIN Corporation, and Schwa-medico GmbH.

Segmentation:

The global acupuncture market is segmented on the basis of component type, application, end user, and region.

By component, the global acupuncture market is segmented into services and products.

By application, the global acupuncture market is segmented into pain syndrome illnesses, gynecological disorders, psychological disorders, and others.

By end use, the acupuncture market is segmented into wellness centers, hospitals and specialty clinics, and research and academic institutes.

Regional Analysis:

By region, the global acupuncture market insights is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas segment is sub-segmented into the U.S., Canada, and South America. Europe is further categorized into Western Europe, containing Germany, France, the UK, Spain, Italy, and the rest of Western Europe, and Eastern Europe. Asia Pacific is further segmented into Japan, China, India, Australia, South Korea, and the rest of Asia Pacific.

Asia Pacific is likely to retain a dominant share in the global acupuncture market over the forecast period due to the preeminent role played by China in the development and conception of acupuncture. The traditional popularity of acupuncture in China has seen the region hold on to the top spot in the global acupuncture market, while countries around China, such as India, Korea, Australia, and Japan have also emerged as key markets for acupuncture services in recent years. The growing popularity of alternative medicine in these countries and the growing healthcare expenditure, thanks to the growing disposable income of consumers in the region, are likely to drive the acupuncture market in the region over the forecast period.

North America is another leading regional market for acupuncture products and services thanks to the growing influence of the New Age movement, which has led to increasing resistance to conventional Western medicine and increasing acceptance of other, less invasive, and supposedly more effective forms of alternative medicine. The increasing healthcare expenses in the U.S. are also likely to remain a key driver for the acupuncture market, though the lack of insurance coverage could hinder the market from going mainstream.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Cardiac Tamponade Market Players Analysis By Segmentations, Regional Analysis, Future Development by 2032

 

Overview:

The global cardiac tamponade market size can score a CAGR of 5.80 % between 2023 and 2032 that can be considered as the forecast period.

Cardiac tamponade can be defined as the accumulation of fluid inside the sac circling the heart (pericardium), which increases pressure on the heart and makes it difficult for the heart to pump. The end result is curbing in the blood volume. This can cause shortness of breath, light-headedness, weakness, fatigue, cough, and others. This can trigger other diseases and their manifestation can lead to kidney failure, connective tissue diseases, chest trauma, aortic rupture, hypothyroidism, pericarditis,  tuberculosis etc. It can be life-threatening if not treated in time.

The cardiac tamponade market insight is gaining significant attention as patients are often registering symptoms that are direct results of the disease. In addition, the healthcare sector is witnessing a steep surge in investment that can trigger better research and development. People are now getting backed by reimbursements that is boosting the acknowledgment of the disease as more and more people are now going to physicians to treat the disease. These factors can smoothen up the track for the cardiac tamponade market growth.

Competitive Landscape:

Companies are lining up new products to get into the cardiac tamponade market for This is a strategic move that is for sure would cement their market footing. However, they employ other methods as well like merger, acquisition, and others. These companies have been profiled in detail in the market report by MRFR.

cardiac tamponade market players are Medtronic, Inc., Boston Scientific Corporation, Hitachi, Ltd., St. Jude Medical Inc., Siemens Healthcare Private Limited, Koninklijke Philips N.V., General Electric Company, Toshiba Medical Systems Corporation, and others.

Segmentation:

MRFR’s take on the global market for cardiac tamponade includes various segments to get a closer view of the core of the market. These segments are treatment, diagnosis, and end users. The segmentation has been supported by volume-wise and value-wise analyses.

By diagnosis, the market for cardiac tamponade can be segmented into electrocardiogram (EKG), x-ray, computed tomography (CT), coronary angiography, magnetic resonance imaging (MRI), and others.

By treatment, the market for cardiac tamponade includes surgery and drugs. The surgery segment incorporates pericardiocentesis, thoracotomy and others. The drugs segment covers blood volume expanders, antibiotics, and others.

 

By end users, the market for cardiac tamponade comprises academic & research, hospitals & clinics, and others. The hospitals & clinics segment may find the growth to be substantial in the coming years.

Regional Analysis:

The Americas can be considered the leader of the market as the revenue generated by the region is significantly higher than other regions. There are countries in the region who would trigger growth by their investment capacity, superior infrastructure, better technical integration, and others. North America would gain better heights than South due to the presence of countries like the US and Canada. The expenditure of these two countries for their healthcare budget is relatively higher, which can ensure that the market would proliferate in better ways.

Europe’s market would gain better traction with the presence of countries like the UK, France, Germany, and others. The region is banking on superior research and development facilities.

The APAC market is expecting superior growth due to the investment made by countries like India, China, and others. Japan’s market in such scenarios is quite well-developed. On the other hand, global players are finding the region a suitable investment option where they can increase their profit by tapping on the large population. Hence, their investment is flowing in, which can make substantial changes in the market. The Middle East & Africa market would find distraction in the poor economies of Africa.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Corneal Transplant Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2032

 

Global Corneal Transplant Market   - Overview

Accrediting the kind of growth, the market is witnessing and the growth prospect the market is demonstrating, Market Research Future (MRFR), has recently published a brilliant study report. According to MRFR, the Global Corneal Transplant market size is expected to perceive exponential growth 11.20% CAGR during the forecasted period (2023 -2032).

The global Corneal Transplant Market insights is growing pervasively over last decade. Factors such as increasing prevalence injuries & diseases related to the eye/ sight that fuel the transplants cases are fuelling the market growth to an extent. Also the risk factors for the blindness & eye sight disorders are creating the demand for the better Corneal Transplants and treatment methods in turn, speed up the market growth.

Other factors propelling the market growth include the changing lifestyle owing to the growing urbanization & industrialization coupled with the growing economic conditions that enable access to the quality life & to the improved healthcare worldwide. Advancements in surgeries, fuel the market growth. In addition, factors such as increasing number of surgeries and rising demand for new techniques for the treatment provide major impetus to the market growth.

On the other hand, factors such as prohibitive costs associated with Corneal Transplant and the differential awareness and availability between developing and the developed world are posing challenges to the market growth. Nevertheless, new products and services offered to the developing countries and emerging economies by the well-established market players in the developed countries are filling up this gap. This will resultantly foster the market growth.

Global Corneal Transplant Market   - Competitive Analysis

Global Corneal Transplant market players are

Florida Lions Eye Bank

CorNeat Vision

CorneaGen

San Diego Eye Bank

Alabama Eye Bank

Aurolab

Cornea Biosciences

KERAMED INC.

Price Vision Group

0 LinkoCare LifeSciences AB

Presbia PLC

AJL Ophthalmic SA

DIOPTER

Massachusetts Eye and Ear

The global Corneal Transplant market is a fragmented market with a large number of players. Product development strategy has been curtailed by the excellent efficiency and efficacy of drugs. However, the rise of drug resistance has opened doors for new drug development and is an opportunity for a new market leader. The rise of spurious and counterfeit medicines have reduced the total market revenues and at the same time displaced standard drugs off the market.

Global Corneal Transplant Market      - Segments

For an easy grasp and enhanced understanding, the report - Global Corneal Transplant Market is segmented in to 4 Key dynamics;

 

By Surgery Types       : Comprises - Penetrating Keratoplasty, DSAEK (Descemet Stripping Automated Endothelial Keratoplasty), Endothelial Keratoplasty, Corneal Graft, and Corneal Limbal Stem Cell Transplant among others.

By Indications            : Bullous Keratopathy, Fungal Corneal Ulcer, Keratoconus, Corneal Stromal Dystrophies, and Keratitis among others.

By End Users               : Hospitals & Eye clinics among others.

By Regions                  :  North America, Europe, APAC and Rest of the World.

Global Corneal Transplant Market   - Regional Analysis

Globally, Europe is the largest market for the Corneal Transplant. Factors such as the availability of multiple treatment options, prevention strategy as well as rising influence of organ donation programs, coupled with the increased government emphasis on organ donation policies drive the regional growth of the market. Moreover, increasing prevalence of diabetes in the region are providing impetus to the market growth.

While North America region stands as the second-largest market for Corneal Transplant. This growth attributes to the increasing demand for corneal transplant surgery coupled with the growing prevalence of eye diseases, and vision impairment among people in the region drive the regional market growth. Moreover, growing Centers for Disease Control and Prevention, coupled with the age-related eye diseases such as age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma are leading causes of blindness and vision imparity especially in the United States; such factors foster the regional market growth.

On the other hand the developing regions markets particularly Asia Pacific will be the fastest growing market for Corneal Transplant. Risk factors for the eye diseases such as the ever-increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity provide impetus to the growth of the regional market. Attributing to the availability of qualitative eye care treatment and skilled medical professionals, India has become one of the international medical tourism destinations across the world. This, in turn fuels the growth of corneal transplant market in India resultantly, fostering the growth of the APAC market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Syringe and Needle Market Insights To Witness Notable Growth During the Forecast Period 2023-2032

 

Market Overview-

The global syringe and needle market size is expected to grow USD 14.74 billion by 2032 at a CAGR of 5.90% and surpass its previous revenues over the forecast period of 2023–2032, as per a research report published by Market Research Future (MRFR). The syringe and needle market is growing primarily on account of a large pool of patients who augment the demand for needle and syringe. High prevalence of blood-borne diseases leads to a surge in the application of syringes and needles which fuels the market growth. The global geriatric population is increasing and contributing significantly to the market growth. This demographic is at high risk for chronic diseases, and the natural aging process weakens the body leading to increased overall medical visits. Increased demand for hypodermic needles which prevent the risk of needle-stick injuries also aids the growth of the market. Implementation of vaccination programs for diseases such as hepatitis, polio, rubella, tetanus, etc., also induces demand for needles and syringes which help in market expansion. Increase in a number of injectable drugs approved by the FDA also propels the market for syringes and needles. However, the growth of the market might be hindered by the risk associated with re-use and sharing of needles and syringes. Reuse of needles exposes consumers to the risk of acquiring diseases such as HIV and hepatitis C which is a major setback and constrain to the market growth. Risk of needlestick injuries and availability of alternatives also hinders the growth of the market. The market growth might be threatened by the introduction of needleless alternatives to meet the demands of a minimally invasive medical procedures.

Competitive Landscape

Global Syringe and Needle Market Players include

·         B. Braun Medical Inc.,

·         Terumo Corporation,

·         Albert David Ltd,

·         Covidien Plc,

·         Smiths Medical, and

·         Connecticut Hypodermics Inc.

 

Segmentation

The global syringes and needle market insights has been segmented based on type, therapeutic application, usability, and end-user. By type, the market has been segmented into Blood Collection, Intravenous, and Catheter. By therapeutic application, the market has been segmented into General Surgery and Diagnostic. By usability, the market has been segmented into disposable and reusable. By end user, the market has been segmented into Hospitals & Clinics and Home Care.

 

Regional Analysis

The key markets of the global syringes and needle market include North America, Europe, Asia Pacific and the Middle East & Africa. North America accounts for the majority share of the global market owing to the prevalence of chronic diseases in the region coupled with increased R&D activities which induce the demand of the market. Additionally, the presence of a large customer base in the region also propels the market growth. Europe is the second largest market owing to increased R&D spending by pharmaceuticals and biotechnology sector in the region. Presence of a developed healthcare sector also supports the market growth in the region. Asia Pacific is expected to be the fastest growing market over the forecast period. The growth in the region would be favored by the prevalence of chronic diseases in the region which escalates the need for treatment and growing research and development in the field of life sciences in the region.  The Middle East & Africa region is expected to exhibit the least growth over the forecast period due to less expenditure on healthcare and limited growth of the healthcare sector in the region.

 

 

Industry Updates

An American pharmacy, Sunrise Pharmacy is reportedly accepting discarded needles found in public spaces for a reward of 5 cents per used needle. The move is an attempt to solve the issue of discarded drug paraphernalia. 

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America